Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microscopy, Confocal | 3 | 2020 | 663 | 0.840 |
Why?
|
| Microscopy, Fluorescence | 3 | 2020 | 769 | 0.820 |
Why?
|
| Pathology, Surgical | 2 | 2018 | 81 | 0.780 |
Why?
|
| Biopsy, Large-Core Needle | 3 | 2020 | 134 | 0.670 |
Why?
|
| Catheter Ablation | 3 | 2018 | 620 | 0.570 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 592 | 0.500 |
Why?
|
| Kidney Neoplasms | 5 | 2021 | 3022 | 0.450 |
Why?
|
| Radiography, Interventional | 2 | 2016 | 305 | 0.440 |
Why?
|
| Gastrostomy | 1 | 2014 | 180 | 0.430 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 316 | 0.400 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 2291 | 0.400 |
Why?
|
| Vena Cava Filters | 3 | 2017 | 88 | 0.400 |
Why?
|
| Catheters, Indwelling | 1 | 2014 | 374 | 0.390 |
Why?
|
| Ambulatory Care | 1 | 2014 | 554 | 0.350 |
Why?
|
| Neoplasms | 8 | 2020 | 15193 | 0.240 |
Why?
|
| Genetics | 1 | 2003 | 27 | 0.230 |
Why?
|
| Prejudice | 1 | 2003 | 57 | 0.230 |
Why?
|
| Embolization, Therapeutic | 2 | 2020 | 551 | 0.230 |
Why?
|
| Genetic Research | 1 | 2003 | 63 | 0.230 |
Why?
|
| Venous Thromboembolism | 2 | 2017 | 335 | 0.220 |
Why?
|
| Social Class | 1 | 2003 | 310 | 0.210 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2022 | 75 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2021 | 2326 | 0.200 |
Why?
|
| Hypersplenism | 1 | 2020 | 23 | 0.190 |
Why?
|
| Pedigree | 1 | 2003 | 1890 | 0.180 |
Why?
|
| Ablation Techniques | 1 | 2021 | 148 | 0.170 |
Why?
|
| Colitis | 1 | 2022 | 340 | 0.170 |
Why?
|
| Optical Imaging | 1 | 2020 | 157 | 0.160 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2018 | 55 | 0.160 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 117 | 0.160 |
Why?
|
| Bone Neoplasms | 2 | 2022 | 2576 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 81 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2018 | 96 | 0.150 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2017 | 85 | 0.150 |
Why?
|
| Ascites | 1 | 2017 | 198 | 0.150 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 297 | 0.140 |
Why?
|
| Hypertension, Portal | 1 | 2017 | 124 | 0.140 |
Why?
|
| Renal Artery | 1 | 2016 | 79 | 0.140 |
Why?
|
| Rare Diseases | 1 | 2019 | 351 | 0.140 |
Why?
|
| Nanomedicine | 1 | 2016 | 54 | 0.140 |
Why?
|
| Pneumonia | 1 | 2022 | 751 | 0.140 |
Why?
|
| Chest Tubes | 1 | 2016 | 101 | 0.140 |
Why?
|
| Cryosurgery | 1 | 2017 | 167 | 0.140 |
Why?
|
| Hydrogels | 1 | 2016 | 123 | 0.140 |
Why?
|
| Urogenital Neoplasms | 1 | 2016 | 108 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2016 | 153 | 0.130 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 270 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 846 | 0.130 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 882 | 0.130 |
Why?
|
| Osteosarcoma | 1 | 2022 | 929 | 0.130 |
Why?
|
| Aneurysm, False | 1 | 2016 | 153 | 0.130 |
Why?
|
| Life Expectancy | 1 | 2015 | 129 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 600 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 992 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 1033 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 321 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 837 | 0.120 |
Why?
|
| Middle Aged | 15 | 2021 | 86204 | 0.120 |
Why?
|
| Liposomes | 1 | 2016 | 684 | 0.120 |
Why?
|
| Humans | 26 | 2022 | 261506 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 550 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2014 | 232 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 117 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 245 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 255 | 0.110 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 1022 | 0.110 |
Why?
|
| Neoplasms, Second Primary | 1 | 2021 | 1350 | 0.110 |
Why?
|
| Arteries | 1 | 2014 | 274 | 0.110 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2015 | 388 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2022 | 3251 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 1586 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2014 | 337 | 0.100 |
Why?
|
| Nephrectomy | 1 | 2016 | 779 | 0.100 |
Why?
|
| Male | 16 | 2021 | 123000 | 0.100 |
Why?
|
| Female | 17 | 2021 | 141928 | 0.100 |
Why?
|
| Aged | 12 | 2021 | 70117 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2021 | 37905 | 0.090 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 29902 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 4971 | 0.090 |
Why?
|
| Aorta | 1 | 2014 | 692 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 1162 | 0.090 |
Why?
|
| Sarcoma | 1 | 2019 | 1725 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 81 | 0.080 |
Why?
|
| Models, Biological | 1 | 2017 | 3254 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3230 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 11538 | 0.070 |
Why?
|
| Child Development | 1 | 2008 | 255 | 0.070 |
Why?
|
| Image-Guided Biopsy | 2 | 2020 | 327 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 341 | 0.070 |
Why?
|
| Young Adult | 4 | 2019 | 21445 | 0.070 |
Why?
|
| Lung | 1 | 2016 | 3151 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 7551 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2008 | 644 | 0.060 |
Why?
|
| Hinduism | 1 | 2003 | 2 | 0.060 |
Why?
|
| United Nations | 1 | 2003 | 11 | 0.060 |
Why?
|
| Quality of Life | 1 | 2017 | 4532 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5319 | 0.060 |
Why?
|
| India | 1 | 2003 | 301 | 0.060 |
Why?
|
| Politics | 1 | 2003 | 74 | 0.060 |
Why?
|
| Genetics, Population | 1 | 2003 | 242 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2021 | 32848 | 0.050 |
Why?
|
| Adult | 6 | 2019 | 77950 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5542 | 0.050 |
Why?
|
| Survival Rate | 3 | 2021 | 12221 | 0.050 |
Why?
|
| Splenic Artery | 1 | 2020 | 50 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2019 | 70 | 0.050 |
Why?
|
| Kidney | 2 | 2021 | 2146 | 0.050 |
Why?
|
| Time Factors | 1 | 2014 | 12926 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 4892 | 0.040 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2021 | 167 | 0.040 |
Why?
|
| Platelet Count | 1 | 2020 | 490 | 0.040 |
Why?
|
| Adolescent | 3 | 2017 | 31252 | 0.040 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2019 | 109 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2018 | 35 | 0.040 |
Why?
|
| Liposarcoma | 1 | 2019 | 214 | 0.040 |
Why?
|
| Mesoderm | 1 | 2019 | 404 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 459 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 209 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2016 | 45 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2017 | 429 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2017 | 9180 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2016 | 62 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 657 | 0.030 |
Why?
|
| Portal Vein | 1 | 2017 | 355 | 0.030 |
Why?
|
| Brain | 1 | 2008 | 4113 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 335 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 557 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 329 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 750 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 1756 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2017 | 690 | 0.030 |
Why?
|
| Inpatients | 1 | 2018 | 678 | 0.030 |
Why?
|
| Biopsy | 1 | 2021 | 3443 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 716 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 1204 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1363 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 14889 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 2488 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2864 | 0.030 |
Why?
|
| Stents | 1 | 2017 | 1096 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 4758 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1014 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 2738 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 4367 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 1904 | 0.020 |
Why?
|
| Anisotropy | 1 | 2008 | 181 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 6311 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 15862 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 5673 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 3890 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 5112 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2330 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 1085 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10001 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8865 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 1225 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8873 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 2139 | 0.010 |
Why?
|
| Child | 2 | 2017 | 29154 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 6869 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 10331 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17523 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 13658 | 0.010 |
Why?
|
| United States | 1 | 2017 | 15433 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 5377 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 15179 | 0.010 |
Why?
|